肝细胞衍生的Igκ通过稳定电子转移黄蛋白亚单元α来促进脂肪酸β-氧化,促进HCC的进展

Jingjing Guo1, Huining Gu1, Sha Yin1

  • 1Department of Immunology, School of Basic Medical Sciences, NHC Key Laboratory of Medical Immunology, Peking University, Beijing, 100191, China.

概括

肝细胞衍生免疫球蛋白卡帕 (Igκ) 通过破坏脂肪酸代谢驱动肝细胞癌 (HCC). 向Igκ/ETFA轴为HCC治疗提供了一个潜在的治疗策略.